浏览全部资源
扫码关注微信
1.长春中医药大学药学院,长春 130117
2.长春中医药大学临床医学院,长春 130117
硕士研究生。研究方向:中药抗炎症性肠病作用机制。E-mail:1609497176@qq.com
教授,硕士生导师,博士。研究方向:中药抗常见多发病作用机制。E-mail:37363266@qq.com
收稿日期:2024-06-18,
修回日期:2024-10-25,
录用日期:2024-10-29,
纸质出版日期:2025-02-28
移动端阅览
代鑫,王莹,任鑫悦等.芍药苷对溃疡性结肠炎小鼠氧化应激的影响及机制 Δ[J].中国药房,2025,36(04):427-433.
DAI Xin,WANG Ying,REN Xinyue,et al.Effects and mechanism of paeoniflorin on oxidative stress of ulcerative colitis mice[J].ZHONGGUO YAOFANG,2025,36(04):427-433.
代鑫,王莹,任鑫悦等.芍药苷对溃疡性结肠炎小鼠氧化应激的影响及机制 Δ[J].中国药房,2025,36(04):427-433. DOI: 10.6039/j.issn.1001-0408.2025.04.07.
DAI Xin,WANG Ying,REN Xinyue,et al.Effects and mechanism of paeoniflorin on oxidative stress of ulcerative colitis mice[J].ZHONGGUO YAOFANG,2025,36(04):427-433. DOI: 10.6039/j.issn.1001-0408.2025.04.07.
目的
2
基于腺苷一磷酸活化的蛋白激酶(AMPK)/核转录因子红系2相关因子2(Nrf2)通路,探讨芍药苷对小鼠溃疡性结肠炎(UC)氧化应激的影响及潜在机制。
方法
2
将雄性BALB/c小鼠随机分为对照组,模型组,抑制剂组(AMPK抑制剂Compound C 20 mg/kg),芍药苷低、中、高剂量组(芍药苷12.5、25、50 mg/kg)、芍药苷高+抑制剂组(芍药苷50 mg/kg+Compound C 20 mg/kg),每组8只。除对照组外,其余各组小鼠均自由饮用4%葡聚糖硫酸钠溶液5 d以构建UC模型。随后,各药物组小鼠灌胃或腹腔注射相应药液,每天1次,连续7 d。实验期间,记录各组小鼠体重的变化情况;末次给药24 h后,检测其结肠长度,结肠组织中丙二醛(MDA)含量及超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-Px)活性,观察其结肠组织病理学形态、肠上皮细胞间紧密连接情况并进行组织病理学评分,检测其结肠组织中AMPK、Nrf2 mRNA及AMPK、Nrf2、血红素加氧酶1(HO-1)、闭合蛋白 (occludin)、密封蛋白1(claudin-1)蛋白的表达情况。
结果
2
与模型组比较,芍药苷各剂量组小鼠结肠组织中炎症细胞浸润、隐窝受损等病理改变均有所恢复,肠上皮细胞间紧密连接受损情况均有所改善;其体重,结肠长度,SOD、GSH-Px活性,以及AMPK蛋白的磷酸化水平,Nrf2、HO-1、occludin、claudin-1蛋白和AMPK、Nrf2 mRNA的表达均显著升高、延长或上调,MDA含量及组织病理学评分均显著降低(
P
<0.05或
P
<0.01),而抑制剂组上述指标与模型组相当(
P
>0.05)或更差(
P
<0.05或
P
<0.01)。加用抑制剂可显著逆转高剂量芍药苷对上述指标的改善作用(
P
<0.01)。
结论
2
芍药苷可修复小鼠肠上皮细胞损伤,改善上皮细胞间紧密连接,并上调相关蛋白、促抗氧化分子的表达和释放,从而改善UC;其作用机制可能与激活AMPK/Nrf2抗氧化通路有关。
OBJECTIVE
2
To investigate the effects and potential mechanism of paeoniflorin on oxidative stress of ulcerative colitis (UC) mice based on adenosine monophosphate-activated protein kinase (AMPK)/nuclear factor-erythroid 2-related factor 2 (Nrf2) pathway.
METHODS
2
Male BALB/c mice were randomly divided into control group, model group, inhibitor group (AMPK inhibitor Compound C 20 mg/kg), paeoniflorin low-, medium- and high-dose groups (paeoniflorin 12.5, 25, 50 mg/kg), high-dose of paeoniflorin+inhibitor group (paeoniflorin 50 mg/kg+Compound C 20 mg/kg), with 8 mice in each group. Except for the control group, mice in all other groups were given 4% dextran sulfate sodium solution for 5 days to establish the UC model. Subsequently, mice in each drug group were given the corresponding drug solution intragastrically or intraperitoneally, once a day, for 7 consecutive days. The changes in body weight of mice were recorded during the experiment. Twenty-four hours after the last administration, colon length, malondialdehyde (MDA) content, and activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) in colon tissues were measured; histopathological morphology of colon tissues, tight junctions between intestinal epithelial cells, and histopathological scoring were all observed and evaluated; the mRNA expressions of AMPK and Nrf2, as well as the protein expressions of heme oxygenase-1(HO-1), occludin and claudin-1, were all determined in colon tissue.
RESULTS
2
Compared with model group, paeoniflorin groups exhibited recovery from pathological changes such as inflammatory cell infiltration and crypt damage in the colon tissue, as well as improved tight junction damage between intestinal epithelial cells. Additionally, significant increases or upregulations were observed in body weight, colon length, activities of SOD and GSH-Px, phosphorylation level of AMPK, and protein expression of Nrf2, HO-1, occludin, claudin-1, and mRNA expressions of AMPK and Nrf2; concurrently, MDA content and histopathological scores were significantly reduced (
P
<0.05 or
P
<0.01). In contrast, the inhibitor group showed comparable (
P
>0.05) or worse (
P
<0.05 or
P
<0.01) indicators compared to the model group. Conversely, the addition of AMPK inhibi
tor could significantly reverse the improvement of high- dose paconiflorin (
P
<0.01).
CONCLUSIONS
2
Paeoniflorin can repair intestinal epithelial cell damage in mice, improve tight junctions between epithelial cells, upregulate the expression of related proteins, and promote the expression and secretion of antioxidant-promoting molecules, thereby ameliorating UC; its mechanism may be associated with activating AMPK/Nrf2 antioxidant pathway.
SEGAL J P , LEBLANC J F , HART A L . Ulcerative colitis:an update [J ] . Clin Med(Lond) , 2021 , 21 ( 2 ): 135 - 139 .
张雪侠 , 金建闻 , 刘长河 , 等 . Nrf2/HO-1通路在四神丸保护溃疡性结肠炎小鼠模型肠道损伤中的作用 [J ] . 中国中药杂志 , 2021 , 46 ( 16 ): 4187 - 4192 .
ZHANG X X , JIN J W , LIU C H , et al . Effect of Nrf2/HO-1 signaling pathway in intestinal protection by Sishen pills against ulcerative colitis in mice [J ] . China J Chin Mater Med , 2021 , 46 ( 16 ): 4187 - 4192 .
叶雪珂 , 单国顺 , 付郁 , 等 . 溃疡性结肠炎发病机制及中西医治疗的研究进展 [J ] . 中华中医药学刊 , 2022 , 40 ( 9 ): 158 - 162,281 .
YE X K , SHAN G S , FU Y , et al . Research progress on pathogenesis and traditional Chinese and western medicine treatment of ulcerative colitis [J ] . Chin Arch Tradit Chin Med , 2022 , 40 ( 9 ): 158 - 162,281 .
曾勇 , 朱楷 , 刘煌 . 芍药苷对溃疡性结肠炎小鼠Treg/Th17平衡、氧化应激反应的调节作用 [J ] . 药品评价 , 2021 , 18 ( 21 ): 1306 - 1310 .
ZENG Y , ZHU K , LIU H . Regulation effect of paeoniflorin on Treg/Th17 balance and oxidative stress response in ulcerative colitis mice [J ] . Drug Eval , 2021 , 18 ( 21 ): 1306 - 1310 .
代鑫 , 李柔 , 胡洋 , 等 . 基于AMPK/mTOR自噬通路探讨芍药苷保护溃疡性结肠炎小鼠的作用机制 [J ] . 中国实验方剂学杂志 , 2024 , 30 ( 3 ): 45 - 53 .
DAI X , LI R , HU Y , et al . Protective mechanism of paeo-niflorin on mice with ulcerative colitis based on AMPK/mTOR autophagy pathway [J ] . Chin J Exp Tradit Med Formulae , 2024 , 30 ( 3 ): 45 - 53 .
张晓蕾 , 张凯 , 秦永亭 , 等 . 木犀草素调控AMPK/NLRP3轴介导的细胞焦亡对病毒性心肌炎的保护作用 [J ] . 中国病原生物学杂志 , 2022 , 17 ( 5 ): 514 - 519 .
ZHANG X L , ZHANG K , QIN Y T , et al . Protective effect of luteolin on viral myocarditis by regulating AMPK/NLRP3 axis-mediated pyroptosis [J ] . J Pathog Biol , 2022 , 17 ( 5 ): 514 - 519 .
成宁宁 , 郑晨曦 , 代鑫 , 等 . 黄芩素对葡聚糖硫酸钠诱导的溃疡性结肠炎小鼠的改善作用 [J ] . 中国新药杂志 , 2023 , 32 ( 3 ): 276 - 282 .
CHENG N N , ZHENG C X , DAI X , et al . Protective effect of baicalein on mice with ulcerative colitis induced by dextran sulfate sodium salt [J ] . Chin J New Drugs , 2023 , 32 ( 3 ): 276 - 282 .
张晓梅 , 黄木圣 , 范春娇 , 等 . 近十年溃疡性结肠炎动物模型的研究 [J ] . 中国中医基础医学杂志 , 2022 , 28 ( 1 ): 157 - 160 .
ZHANG X M , HUANG M S , FAN C J , et al . Recent advances in animal models of ulcerative colitis [J ] . J Basic Chin Med , 2022 , 28 ( 1 ): 157 - 160 .
赵颖 , 张小琴 . 中医药修复肠黏膜屏障治疗溃疡性结肠炎的研究进展 [J ] . 中国中医急症 , 2021 , 30 ( 5 ): 936 - 940 .
ZHAO Y , ZHANG X Q . Research progress of traditional Chinese medicine in repairing intestinal mucosal barrier in the treatment of ulcerative colitis [J ] . J Emerg Tradit Chin Med , 2021 , 30 ( 5 ): 936 - 940 .
WANG J , ZHANG C L , GUO C M , et al . Chitosan ameliorates DSS-induced ulcerative colitis mice by enhancing intestinal barrier function and improving microflora [J ] . Int J Mol Sci , 2019 , 20 ( 22 ): 5751 .
WU W C , WANG S S , LIU Q , et al . Metformin protects against LPS-induced intestinal barrier dysfunction by activating AMPK pathway [J ] . Mol Pharm , 2018 , 15 ( 8 ): 3272 - 3284 .
LI B L , GUO Y X , JIA X M , et al . Luteolin alleviates ulcerative colitis in rats via regulating immune response,oxidative stress,and metabolic profiling [J ] . Open Med(Wars) , 2023 , 18 ( 1 ): 20230785 .
王会沙 . 化浊解毒愈疡煎对溃疡性结肠炎大鼠GSH、GSH-Px、IFN-γ表达的影响 [D ] . 石家庄 : 河北医科大学 , 2018 .
WANG H S . Effect of Huazhuo Jiedu Yuyang decoction on the expression of GSH,GSH-Px and IFN-γ in ulcera-tive colitis rats [D ] . Shijiazhuang : Hebei Medical University , 2018 .
邓文娟 . 黄芪汤通过AMPK/Nrf2信号通路抑制氧化应激改善C57小鼠糖尿病肾病足细胞损伤 [D ] . 合肥 : 安徽医科大学 , 2019 .
DENG W J . Huangqi decoction inhibits oxidative stress through AMPK/Nrf2 signaling pathway and improves podocyte injury in C57 mice with diabetic nephropathy [D ] . Hefei : Anhui Medical University , 2019 .
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构